Tethys Bioscience Buys Lipomics

Tethys Bioscience, an Emeryville, Calif.-based developer of multi-biomarker technology, has acquired Lipomics Technologies, a West Sacramento, Calif.-based developer of metabolite profiling technology. No financial terms were disclosed. Thethys has raised $54 million in total VC funding, from firms like Kleiner Perkins Caufield & Byers, Mohr Davidow Ventures, Intel Capital and DAG Ventures. Lipomics had raised an undisclosed amount of funding from firms like DFJ Frontier.

North AmericaUSM&A DealsBriefs